Eppendorf North America is now a sponsor of LabCentral, a shared laboratory space designed to be a catalyst for entrepreneurs and life science startups. The 27,000 square-foot facility is slated for opening November 1, 2013, and will be located at Kendall Square, Cambridge, MA, in the Cambridge Biotech Innovation Hub.
LabCentral received a $5 million grant from the Massachusetts Life Science Center in February of 2013. Triumvirate Environmental and Johnson & Johnson Innovation became founding sponsors shortly thereafter, and Edwards Wildman Palmer joined as a platinum sponsor. Gold sponsors include Novartis Institutes for Biomedical Research, Cushman & Wakefield, and Cooley. MIT Investment Management is LabCentral's real estate partner.
LabCentral, which aims to house as many as 25 life sciences startups employing 70+ high-potential scientists and entrepreneurs, began reviewing applications from scientists, entrepreneurs, and life science startups in July; it has reportedly accepted 12 companies to date.
"Eppendorf has a long tradition of supporting scientists in their work with best-in-class products and support," Matin Khajooei, president and CEO of Eppendorf North America, said in a statement. "LabCentral’s model is unique and will change the way biotechnology companies are built in the future."